Abstract
Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias; in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.
Original language | English (US) |
---|---|
Pages (from-to) | 1741-1748 |
Number of pages | 8 |
Journal | Archives of Internal Medicine |
Volume | 160 |
Issue number | 12 |
DOIs | |
State | Published - Jun 26 2000 |
All Science Journal Classification (ASJC) codes
- Internal Medicine